Navigation Links
Northwest Secures US$4.0 Million in Debt Financing
Date:5/9/2008

BETHESDA, Md., May 9 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC Bulletin Board: NWBO), today announced that Al Rajhi Holdings W.L.L. ("Al Rajhi") has entered into an agreement, executed on May 6 2008, to provide NWBT with debt financing in the amount of US$4.0 million (the "Loan").

Under the terms of the Loan, Northwest will receive US$4.0 million in return for an unsecured promissory note in the principal amount of US$4,240,000 (reflecting an original issue discount of six percent, or US$240,000). The Loan has a term of six months. Al Rajhi may elect to have the original issue discount amount paid at maturity in common stock of NWBT, at a price per share equal to the average closing price of NWBT's common stock on the NASD Over The Counter Bulletin Board over the ten trading days prior to the execution of the Loan agreement.

The Directors of the Company consider, having consulted with the Company's Nominated Adviser, Collins Stewart Europe Limited, that the Loan is fair and reasonable in the circumstances insofar as the Company's shareholders are concerned. In giving its advice to the Directors, Collins Stewart Europe Limited relied on their commercial assessment.

Alton L. Boynton, Chief Executive Officer of NWBT said:

"We are delighted to have secured this Loan from Al Rajhi. Since investing in our IPO on AIM in June 2007, Al Rajhi has accumulated a significant stake in Northwest and currently holds in excess of ten per cent of our issued and outstanding common stock. We appreciate their support for the Company and our DCVax(R) technology. The Loan will enable us to continue moving our programs forward aggressively, with minimal dilution for existing shareholders."

About NWBT

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, with limited toxicity, on a cost-effective ba
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
2. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
3. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
4. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
5. D-Pharm Secures Funding From Israels Chief Scientists Office
6. Aerovance Secures $20 Million in Debt Financing
7. Amarin Secures Global Intellectual Property Rights for Lipid Programs
8. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
9. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
10. Taligen Therapeutics Secures Series B Financing
11. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wswire/ -- Myriant Technologies LLC ("Myriant"), a...r of renewable bio-chemicals, Uhde Corporation of...e GmbH, one of the world,s leading engineering con...or the engineering, procurement & construction...based on renewable feedstocks. The execution of t...
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...ws Accurate Marketing Claims Designed with Input f...ation,s leading livestock,cloning companies announ...management system that will allow food companies t...food processing chain., The program was developed...e last year with all critical participants in the ...
...., Dec. 19 SleepQuest, the leader in,at-home diag...nounced the,launch of an improved version of its m...r to better support its community of,patients, fam... increasing demand for in-home sleep testing and s...ite to meet the needs of our,expanding patient pop...
..., Dec. 19 BioForm Medical,Inc. (Nasdaq: BFRM ) t...Officer, will present a company overview at the up...being held from January 7-10, 2008. BioForm,Medica...y 7th, 2008 at 8:30,a.m. PST (11:30 am EST) at the... live and archived copy of the webcast of BioForm ...
Other Biology Technology:Top U.S. Cloning Companies Announce New System to Track Cloned Livestock 2SleepQuest Launches Updated Web Site 2BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008 2
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
(Date:11/6/2009)...ills, MI-based Law Enforcement Intelligent Devices...and patent-pending Biometric Access Control System...uman Services, National Institutes of Health (NIH)...pport the NIH,s entire police force that is respon... agency. The project is expected to be completed ...
(Date:11/5/2009)... (NABT) will recognize Leonard C. Yannielli, profe...mmunity College (NVCC) in Waterbury, Connecticut, ... NABT annual professional development conference t... , The Evolution Education Award is cosponsored ...(AIBS) and Biological Sciences Curriculum Study (B...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1Assessing Embryo Metabolism May Aid IVF Success 59948 1Assessing Embryo Metabolism May Aid IVF Success 59948 2
...f a space-age, low-gravity training machine used b...mpacts on muscles and joints by nearly half when s...ir body weight. , The new study has implications ...njuries and for ordinary people returning from kne...sor Rodger Kram of CU-Boulder,s integrative physio...
...resistance on the rise, tuberculosis is emerging a... , But now, innovative research at Weill Cornell ...culosis has an as yet unsuspected weakness -- one.... , "Using novel techniques, we have identified a...nse that M. tuberculosis mounts against the acid...
...ay have found a defense against the Black Plague, ...ation in the Middle Ages and which government agen... Professor Henry Daniell and his team have develop...ffective against the plague. Findings of his Natio...appear in the August edition of Infection and Imm...
Other Biology News:Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 2Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 3Potential new drug target to fight tuberculosis identified 2Potential new drug target to fight tuberculosis identified 3UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3
F-12K Nutrient Mixture Kaighn's Modification (1x) liquid from Invitrogen
Agarose-HR from Ambion
Combination Roto Shake Genie from Femto Scientific
Mouse Anti-CNG Channel Monoclonal Antibody, Unconjugated, Clone CNC 9C1 from ABR-Affinity BioReagents
Biology Products: